On May 30th, the NSW Showcase event was hosted by TIA and MTPConnect. This event was dedicated to showcase Australia’s national research infrastructure for advancing therapeutic product developments. This showcase also provided detailed insights into available funding to support NCRIS access. Special guest Terry O’Riordan from AusIndustry gave an update on opportunities for matched grant funding through the “Industry Growth Program,” which supports SME researchers.
Featured Speakers included:
- Therapeutic Innovation Australia (TIA)
- Bioplatforms Australia
- Australian National Fabrication Facility (ANFF)
- Phenomics Australia
- National Measurement Institute (NMI)
- Australian Nuclear Science and Technology Organisation (ANSTO)
Following the successful NSW Showcase event, Dr Heather Donaghy from TIA visited ANSTO and the National Measurement Institute (NMI). These visits provided a comprehensive overview of the groundbreaking work being conducted at these facilities, showcasing their pivotal roles in supporting therapeutic development and scientific research in Australia.
Along with Dr Elizabeth Stares and Dr Duncan Maclnnis from MTPConnect, Dr Heather Donaghy toured ANSTO located in Lucas Heights, NSW, guided by Gita Rahardjo, Commercial Technical Consultant. ANSTO, one of Australia’s largest public research organisations in nuclear science and technology, showcased its diverse capabilities, including the development of radiopharmaceuticals for imaging and therapy purposes, gamma irradiation for pre-surgical implant sterilisation, and the National Deuteration Facility (NDF), which enables detailed analysis of molecular structures.
The NMI plays a vital role in the establishment and maintenance of Australia’s physical, chemical and biological measurement standards. Stephanie Meoz-King kindly guided the tours at both Lindfield and North Ryde locations. The NMI’s capabilities encompass crucial scientific and industrial applications, including nanoscale dimensional measurements using multiple instruments to detect size and mass of particles at a fine resolution, bioanalysis services providing DNA and RNA-based standards for assays, and high-purity organic chemistry reference materials with known concentrations for precise and consistent chemical analysis.
TIA remains committed to engaging with leading research infrastructures and industry partners to enhance Australia’s position at the forefront of global scientific innovation.
